- Pattern Recognition
- GlueHunter 1.0
- LeadHunter 2.0
- ERST-LAB
Pattern Recognition 
AI Technology
								ERSTEQ’s pattern recognition platform deciphers structural and dynamic signatures—analyzing surface complementarity, conformational shifts, and dynamic binding interfaces—to predict biologically relevant interactions and unlock undruggable targets.
Proprietary pattern recognition technology optimized for the evolving landscape of novel therapeutic modalitiesGlueHunter 1.0
AI-Powered Rational Molecular Glue Discovery PlatformGlueHunter1.0 integrates two specialized engines that accelerate the discovery Neo-degradable targets and molecular glues/PPI modulators through complementary pattern recognition analysis
- 
										1Neo-substrate Identification Analyzes surface interactions, target recruitment and anchoring factors, and structural complementarity to identify novel neo-substrates with high therapeutic potential.
- 
										2Molecular Glue Discovery Extracts geometric and topological features, maps 3D conformational changes, and profiles dynamic binding interfaces to enable the rational design of tailored molecular glues.
									Applications
									Enables the end-to-end discovery of molecular glue degraders and 
									stabilizers, the identification of novel neo-substrates, and the design of 
									PPI modulators to precisely regulate protein–protein interactions, driving 
									therapeutic innovation across oncology, neurodegeneration, and other disease areas.
								
 
																
								LeadHunter 2.0
Target-centric, Motion & Motility-driven Drug Discovery Platform
									LeadHunter 2.0 analyzes therapeutically actionable patterns through atomic-level assessment of three-dimensional structural data, 
									powered by the dynamic conformational changes of target proteins. 
This approach goes beyond static models to reveal 
									hidden opportunities for drug intervention.
								
- 
										1Hot Spot Identification Evaluates binding affinity, functional and disease-associated mechanisms, and structural complementarity to pinpoint functionally relevant binding sites with high druggability.
- 
										2Motion & Motility Analysis Profiles geometric and topological features, captures 3D conformational changes, and maps dynamic binding interfaces to uncover previously inaccessible regulatory sites.
									Applications
									Enables the discovery of small molecule regulators—including inhibitors 
									and activators—designed to precisely modulate target protein function.
								
ERST- LAB
Full-cycle (end-to-end, from in silico to in vivo) validation is delivered from molecule to animal, with real-time feedback integrated into the AI drug discovery platform—powering smarter, faster drug discovery. In addition, the validation system provides target-specific, high-precision efficacy assessment to support confident decision-making in drug development.
Rapid, Continuously improving of Drug discovery
